Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

216 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years.

NCT01973218

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • 06 Kosin University Gospel Hospital 34, amnam-dong Seo-gu, Busan, South Korea
  • 05 YuKorea University Ansan Hospital 23, Jeokgeum-ro, Danwon-gu Ansan-si, Gyeonggi-do, South Korea
  • 04 Pusan National University Yangsan Hospital 20 Geumo-ro, Mulgeum-eup Yangsan, Gyeongsangnam-do, South Korea
  • 07 Seoul National University Bundang Hospital 82, Gumi-ro 173 Beon-gil Bundang-gu, Seongnam, South Korea
View Trial Details
Completed

One Year Antibody Persistence After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Recombinant Vaccine Administered Starting From 12 Months of Age and Response to a Third Dose Boost or Two Catch-Up Doses Starting at 24 Months of Age

NCT01139021

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • amostatná ordinace praktického lékaře pro děti a dorost Jindřichův Hradec Hradec, Czechia
  • Dětské oddělení nemocnice Náchod Náchod, Czechia
  • Dětské oddělení nemocnice Pardubice Pardubice, Czechia
  • University of Tampere Medical School, Vaccine Research Center Tampere Biokatu 10, Pirkanmaa, Finland
View all 19 locations
View Trial Details
Completed

Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants

NCT00937521

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Hospital Privado de Córdoba CMC SA Naciones Unidas 346, Córdoba Province, Argentina
  • Universidad de Chile, Av Independencia 1027 Comuna de Independencia, Santiago Metropolitan, Chile
  • Consultorio Manuel Bustos Lo Cruzat 486, Quilicura, Santiago Metropolitan, Chile
  • Samostatna ordinace praktickeho lekare pro deti a dorost O. Kubina 17, Boskovice, Czechia
View all 38 locations
View Trial Details
Completed

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

NCT00721396

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +3 more
Locations
  • Novartis Investigational Site Nr. 59 Edegem, Antwerpen, Belgium
  • Novartis Investigational Site Nr. 55 Antwerp, Belgium
  • Study Investigational Site Nr. 60 Brussels, Brussels Capital, Belgium
  • Novartis Investigational Site Nr. 57 Brussels, Brussels Capital, Belgium
View all 60 locations
View Trial Details

Related conditions